Biotech · Private company
NImmune Biopharma
Track this companyFree. Adds NImmune Biopharma to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- BT-11 (440 mg)Phase 2 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- BT-11 (880 mg)Phase 2 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- BT-11 880 mgPhase 2 · Crohn's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- BT-11Phase 1 · Normal Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Efficacy and Safety of Oral BT-11 in Moderate to Severe Crohn's DiseasePHASE2 · TERMINATED · started May 5, 2021ClinicalTrials.gov NCT03870334 · fetched Nov 12, 2026
- Efficacy and Safety of Oral BT-11 in Ulcerative ColitisPHASE2 · COMPLETED · started Aug 14, 2019ClinicalTrials.gov NCT03861143 · fetched Nov 12, 2026
- Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female VolunteersPHASE1 · COMPLETED · started Jul 6, 2018ClinicalTrials.gov NCT03860571 · fetched Nov 12, 2026